Longitudinal single-cell analysis of SARS-CoV-2-reactive B cells uncovers persistence of early-formed, antigen-specific clones
(2023) In JCI Insight 8(1). p.1-19- Abstract
 Understanding persistence and evolution of B cell clones after COVID-19 infection and vaccination is crucial for predicting responses against emerging viral variants and optimizing vaccines. Here, we collected longitudinal samples from patients with severe COVID-19 every third to seventh day during hospitalization and every third month after recovery. We profiled their antigen-specific immune cell dynamics by combining single-cell RNA-Seq, Cellular Indexing of Transcriptomes and Epitopes by Sequencing (CITE-Seq), and B cell receptor-Seq (BCR-Seq) with oligo-tagged antigen baits. While the proportion of Spike receptor binding domain-specific memory B cells (MBC) increased from 3 months after infection, the other Spike- and... (More)
Understanding persistence and evolution of B cell clones after COVID-19 infection and vaccination is crucial for predicting responses against emerging viral variants and optimizing vaccines. Here, we collected longitudinal samples from patients with severe COVID-19 every third to seventh day during hospitalization and every third month after recovery. We profiled their antigen-specific immune cell dynamics by combining single-cell RNA-Seq, Cellular Indexing of Transcriptomes and Epitopes by Sequencing (CITE-Seq), and B cell receptor-Seq (BCR-Seq) with oligo-tagged antigen baits. While the proportion of Spike receptor binding domain-specific memory B cells (MBC) increased from 3 months after infection, the other Spike- and Nucleocapsid-specific B cells remained constant. All patients showed ongoing class switching and sustained affinity maturation of antigen-specific cells, and affinity maturation was not significantly increased early after vaccine. B cell analysis revealed a polyclonal response with limited clonal expansion; nevertheless, some clones detected during hospitalization, as plasmablasts, persisted for up to 1 year, as MBC. Monoclonal antibodies derived from persistent B cell families increased their binding and neutralization breadth and started recognizing viral variants by 3 months after infection. Overall, our findings provide important insights into the clonal evolution and dynamics of antigen-specific B cell responses in longitudinally sampled patients infected with COVID-19.
(Less)
- author
 - publishing date
 - 2023-01-10
 - type
 - Contribution to journal
 - publication status
 - published
 - keywords
 - Humans, SARS-CoV-2, COVID-19, B-Lymphocytes, Plasma Cells, Clone Cells
 - in
 - JCI Insight
 - volume
 - 8
 - issue
 - 1
 - pages
 - 1 - 19
 - publisher
 - The American Society for Clinical Investigation
 - external identifiers
 - 
                
- pmid:36445762
 - scopus:85145966419
 
 - ISSN
 - 2379-3708
 - DOI
 - 10.1172/jci.insight.165299
 - language
 - English
 - LU publication?
 - no
 - id
 - e3688caa-ecac-45f3-9854-651e571f3338
 - date added to LUP
 - 2023-11-16 12:55:16
 - date last changed
 - 2025-10-29 08:44:01
 
@article{e3688caa-ecac-45f3-9854-651e571f3338,
  abstract     = {{<p>Understanding persistence and evolution of B cell clones after COVID-19 infection and vaccination is crucial for predicting responses against emerging viral variants and optimizing vaccines. Here, we collected longitudinal samples from patients with severe COVID-19 every third to seventh day during hospitalization and every third month after recovery. We profiled their antigen-specific immune cell dynamics by combining single-cell RNA-Seq, Cellular Indexing of Transcriptomes and Epitopes by Sequencing (CITE-Seq), and B cell receptor-Seq (BCR-Seq) with oligo-tagged antigen baits. While the proportion of Spike receptor binding domain-specific memory B cells (MBC) increased from 3 months after infection, the other Spike- and Nucleocapsid-specific B cells remained constant. All patients showed ongoing class switching and sustained affinity maturation of antigen-specific cells, and affinity maturation was not significantly increased early after vaccine. B cell analysis revealed a polyclonal response with limited clonal expansion; nevertheless, some clones detected during hospitalization, as plasmablasts, persisted for up to 1 year, as MBC. Monoclonal antibodies derived from persistent B cell families increased their binding and neutralization breadth and started recognizing viral variants by 3 months after infection. Overall, our findings provide important insights into the clonal evolution and dynamics of antigen-specific B cell responses in longitudinally sampled patients infected with COVID-19.</p>}},
  author       = {{Scharf, Lydia and Axelsson, Hannes and Emmanouilidi, Aikaterini and Mathew, Nimitha R and Sheward, Daniel J and Leach, Susannah and Isakson, Pauline and Smirnov, Ilya V and Marklund, Emelie and Miron, Nicolae and Andersson, Lars-Magnus and Gisslén, Magnus and Murrell, Ben and Lundgren, Anna and Bemark, Mats and Angeletti, Davide}},
  issn         = {{2379-3708}},
  keywords     = {{Humans; SARS-CoV-2; COVID-19; B-Lymphocytes; Plasma Cells; Clone Cells}},
  language     = {{eng}},
  month        = {{01}},
  number       = {{1}},
  pages        = {{1--19}},
  publisher    = {{The American Society for Clinical Investigation}},
  series       = {{JCI Insight}},
  title        = {{Longitudinal single-cell analysis of SARS-CoV-2-reactive B cells uncovers persistence of early-formed, antigen-specific clones}},
  url          = {{http://dx.doi.org/10.1172/jci.insight.165299}},
  doi          = {{10.1172/jci.insight.165299}},
  volume       = {{8}},
  year         = {{2023}},
}
